Plasma S100A8/A9 levels correlate with blood neutrophil counts in both healthy individuals [16] and MI patients [17], and the ABR-238901 treatment reduces both circulating neutrophil numbers and plasma S100A8/A9 in mice with MI [8]. The gene discussed is S100A8; the disease is myocardial infarction.